Follow
Fatma Babikr
Fatma Babikr
Research Assistant, CellCarta
Verified email at mail.usask.ca
Title
Cited by
Cited by
Year
TLR9 agonist enhances radiofrequency ablation-induced CTL responses, leading to the potent inhibition of primary tumor growth and lung metastasis
A Xu, L Zhang, J Yuan, F Babikr, A Freywald, R Chibbar, M Moser, ...
Cellular & Molecular Immunology 16 (10), 820-832, 2019
442019
Distinct roles but cooperative effect of TLR3/9 agonists and PD-1 blockade in converting the immunotolerant microenvironment of irreversible electroporation-ablated tumors
F Babikr, J Wan, A Xu, Z Wu, S Ahmed, A Freywald, R Chibbar, Y Wu, ...
Cellular & Molecular Immunology 18 (12), 2632-2647, 2021
222021
combining irreversible electroporation (IRE) with TLR3/9 agonists and PD-1 blockade for potent anti-tumor immunity
FI Babikr
University of Saskatchewan, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–3